Supplementary Figure 2 from the Antitumor Activity of Homoharringtonine Against Human Mast Cells Harboring the KIT D816V Mutation

Yanli Jin,Zhongzheng Lu,Kaiyuan Cao,Yunhui Zhu,Qi Chen,Feng Zhu,Chenchen Qian,Jingxuan Pan

DOI: https://doi.org/10.1158/1535-7163.22485917.v1

2023-01-01

Abstract:Supplementary Figure 2 from The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Wenqun Zhong,Zhang Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23952936.v1

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Amanda Herzog,Yansong Bian,Robert Vander Broek,Bradford Hall,Jamie Coupar,Hui Cheng,Anastasia L. Sowers,John D. Cook,James B. Mitchell,Zhong Chen,Ashok B. Kulkarni,Carter Van Waes

DOI: https://doi.org/10.1158/1078-0432.22445265

2023-01-01

Abstract:PDF file - 1957K, Treatment in UM-SCC xenograft and Tgfbr1/Pten KO mice.
Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375074

2023-01-01

Abstract:Supplementary Figure 2 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplementary Figure 2 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Ron Bose,Shyam M. Kavuri,Adam C. Searleman,Wei Shen,Shen Dong,Daniel C. Koboldt,John Monsey,Nicholas Goel,Adam B. Aronson,Shunqiang Li,X. Cynthia,Li Ding,Elaine R. Mardis,Matthew J. Ellis

DOI: https://doi.org/10.1158/2159-8290.22528739

2023-01-01

Abstract:PDF file - 86K, Flow cytometry measurements of cell-surface expression of HER2 mutants
Supplementary Figure 2 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Stephen R. Mattarollo,Sherene Loi,Helene Duret,Yuting Ma,Laurence Zitvogel,Mark J. Smyth

DOI: https://doi.org/10.1158/0008-5472.22388336.v1

2023-01-01

Abstract:Supplementary Figure 2 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Supplementary Figures from Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Wen‐Jia Zuo,Yi‐Zhou Jiang,Yujie Wang,Xiao‐En Xu,Xin Hu,Guangyu Li,Jiong Wu,Gen-Hong Di,Ke‐Da Yu,Zhi‐Ming Shao

DOI: https://doi.org/10.1158/1078-0432.22467669

2023-01-01

Abstract:Supplementary Figure S1. Flowchart of study design. Supplementary Figure S2. Protein structure visualizations of the HER2 somatic mutations. Supplementary Figure S3. HER2 mutations L768S and V773L induce HER2 internalization. Supplementary Figure S4. Kaplan-Meier estimates of relapse-free survival (RFS) according to HER2 mutation in different regions.
Supplementary Figure 1 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Stephen R. Mattarollo,Sherene Loi,Helene Duret,Yuting Ma,Laurence Zitvogel,Mark J. Smyth

DOI: https://doi.org/10.1158/0008-5472.22388339

2023-01-01

Abstract:Supplementary Figure 1 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Supplementary Figure 2 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Hongkui Jin,Renhui Yang,Zhong Zheng,Mally Romero,Jed Ross,Hani Bou-Reslan,Richard A.D. Carano,Ian Kasman,Elaine Mai,Judy Young,Jiping Zha,Zemin Zhang,Sarajane Ross,Ralph Schwall,Gail Colbern,Mark Merchant

DOI: https://doi.org/10.1158/0008-5472.22373643

2023-01-01

Abstract:Supplementary Figure 2 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Supplementary Figure 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Hongkui Jin,Renhui Yang,Zhong Zheng,Mally Romero,Jed Ross,Hani Bou-Reslan,Richard A.D. Carano,Ian Kasman,Elaine Mai,Judy Young,Jiping Zha,Zemin Zhang,Sarajane Ross,Ralph Schwall,Gail Colbern,Mark Merchant

DOI: https://doi.org/10.1158/0008-5472.22373646.v1

2023-01-01

Abstract:Supplementary Figure 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401690

2023-01-01

Abstract:PDF file - 623K, Effects of restoring HIC1 expression in MDA-468 cells.
Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,Haruko Sakurama,Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone

DOI: https://doi.org/10.1158/0008-5472.22377150.v1

2023-01-01

Abstract:Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
Supplementary Figure 3 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Hongkui Jin,Renhui Yang,Zhong Zheng,Mally Romero,Jed Ross,Hani Bou-Reslan,Richard A.D. Carano,Ian Kasman,Elaine Mai,Judy Young,Jiping Zha,Zemin Zhang,Sarajane Ross,Ralph Schwall,Gail Colbern,Mark Merchant

DOI: https://doi.org/10.1158/0008-5472.22373640.v1

2023-01-01

Abstract:Supplementary Figure 3 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Supplementary Figure 7 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Ron Bose,Shyam M. Kavuri,Adam C. Searleman,Wei Shen,Shen Dong,Daniel C. Koboldt,John Monsey,Nicholas Goel,Adam B. Aronson,Shunqiang Li,X. Cynthia,Li Ding,Elaine R. Mardis,Matthew J. Ellis

DOI: https://doi.org/10.1158/2159-8290.22528724.v1

2023-01-01

Abstract:PDF file - 106K, Protein structure modeling suggests that HER2 D769 is located near the HER2-HER3 kinase domain dimer interface
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Dongping Wei,Leslie A. Parsels,David Karnak,Mary A. Davis,Joshua D. Parsels,Amanda C. Marsh,Lili Zhao,Jonathan Maybaum,Theodore S. Lawrence,Yi Sun,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22450100

2023-01-01

Abstract:PDF file - 52K, LB100 causes an increase in pHistone H3 positive cells.
Supplementary Figure 3 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Stephen R. Mattarollo,Sherene Loi,Helene Duret,Yuting Ma,Laurence Zitvogel,Mark J. Smyth

DOI: https://doi.org/10.1158/0008-5472.22388333.v1

2023-01-01

Abstract:Supplementary Figure 3 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Supplementary Figures 1-6 from the Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma

Zan Shen,Zhen Fan Yang,Yi Gao,Ji Cheng Li,Hai Xiao Chen,Ching Chiu Liu,Ronnie T.P. Poon,Sheung Tat Fan,John M. Luk,Kong Hung Sze,Tsai Ping Li,Ren Bao Gan,Ming Liang He,Hsiang Fu Kung,Marie C.M. Lin

DOI: https://doi.org/10.1158/0008-5472.22374489

2023-01-01

Abstract:Supplementary Figures 1-6 from The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma

Supplementary Figure 2 from the Antitumor Activity of Homoharringtonine Against Human Mast Cells Harboring the KIT D816V Mutation

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure 2 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Supplementary Figure 2 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Supplementary Figures from Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Supplementary Figure 1 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Supplementary Figure 2 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Supplementary Figure 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

Supplementary Figure 3 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Supplementary Figure 7 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Supplementary Figure 3 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Supplementary Figures 1-6 from the Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma